California judge affirms ruling for coffee cancer warnings

LOS ANGELES – A Los Angeles judge has issued a final ruling requiring coffee to carry cancer warning labels in California.

Superior Court Judge Elihu Berle issued his decision Monday that Starbucks and other coffee companies failed to show that benefits from drinking coffee outweighed any risks.

The ruling mirrors Berle’s tentative decision issued in March that was expected to stand.

A nonprofit group sued coffee roasters, distributors and retailers under a state law requiring warnings on chemicals that can cause cancer. One is acrylamide, a carcinogen present in coffee.

The coffee industry had claimed the chemical was present at harmless levels and should be exempt from the law because it results naturally from the cooking process to make the beans flavorful. They also pointed to health benefits associated with the brew.

  • Related Posts

    Lilly launches Mounjaro KwikPen in India

    Mumbai, August 14, 2025 — Eli Lilly and Company (India) has rolled out the Mounjaro (tirzepatide) KwikPen across the country, expanding treatment choices for people with type-2 diabetes and those…

    Fortis Q1 Profit Jumps 57%; Expansion Drives Growth

      Gurugram, August 7 – http://Fortis HealthcareFortis Healthcare has reported a 57% year-on-year increase in its net profit for the first quarter of FY2025. The hospital chain posted ₹260 crore…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    NCB Hyderabad raids illegal lab, seizes 69 kg of Alprazolam worth Rs 17.4 crore

    Rajasthan Bans 7 Sub-Standard Medicines

    Rajasthan Bans 7 Sub-Standard Medicines

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    ONESOURCE’s partner receives USFDA tentative approval for Semaglutide Injection

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Ajanta Pharma gets USFDA Form 483 with five observations at Paithan plant

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Obesity drug market to gain as Indians pop the pill and Chinese bring more

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23

    Aurobindo Pharma Rs 800 Cr Buyback Opens Apr 23